SESSION TITLE: COPD Pharmacotherapy
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Saturday, April 16, 2016 at 11:45 AM - 12:45 PM
PURPOSE: To evaluate the clinical efficacy and safety of long term inhalation of nebulized budesonide in elderly COPD patients.
METHODS: 25 elderly COPD patients of stable stage were randomly allocated in 2 treatment groups (group A: budesonide 1mg bid; group B: budesonide 2mg bid) separately. The duration of the study period was 1 year. 15 healthy old men were recruited as normal control. Forced expiratory volume in 1 second (FEV1), blood gas analysis, COPD-assessment test (CAT), glycometabolism and bone metabolism markers were checked before and after treatment.